跳至主要内容
临床试验/CTRI/2024/07/070003
CTRI/2024/07/070003尚未招募2 期

Effect of karanja arka as add on to oral hypoglycemic drugs in type 2 diabetes mellitus using biochemical and QOLID parameters - NI

REEBA LOPEZ0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Participants fulfilling the diagnostic criteria
  • Participants diagnosed with Type 2 Diabetes mellitus within 5 years
  • Participants taking oral hypoglycemic drugs
  • Participants belonging to 30 TO 70 years of age
  • Participants having any or both the blood glucose levels with following ranges
  • FBS 126mg/dl to 250mg/dl
  • PPBS 200mg/dl to 350mg/dl
  • HbA1c greater than or equal to 6.5 to 8

排除标准

  • Participants diagnosed with Type 1 Diabetes mellitus
  • Participants who are known cases of other systemic illness
  • Type 2 Diabetes mellitus patients with complications
  • Participants who are known cases of psychiatric illness
  • Pregnancy and Lactating women
  • Participants having completed any other trail with in past 6 months

研究者

发起方
REEBA LOPEZ

相似试验